Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00001167 · ClinicalTrials.gov registry record
Ultrasound Evaluation of Tongue Movements in Speech and Swallowing
A clinical trial of Polymyositis and Speech Disorder, sponsored by National Institutes of Health Clinical Center (CC).
- Completed
- Registry status
- 570
- Enrollment target
- 1
- Study location
NCT00001167 is a study of Polymyositis and Speech Disorder that has completed, run by National Institutes of Health Clinical Center (CC). The registered enrollment target is 570 participants, below the 1,002-participant average among 8 other Polymyositis trials with a reported enrollment target (43% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00001167, a study of Polymyositis and Speech Disorder, has completed, sponsored by National Institutes of Health Clinical Center (CC).
- COMPLETED
- Registry status
- 570 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will assess the use of ultrasound-a test that uses sound waves to produce images-as a diagnostic tool for evaluating speech and swallowing. The following categories of individuals may be eligible for this study: 1) healthy volunteers between 20 and 85 years old with normal speech and hearing, 2) patients 6 to 85 years old with developmental neurological deficits in speech or swallowing, and 3) patients with tumors of the oral cavity, pharynx or larynx being treated at the Greater Baltimore Medical Center. Participants will undergo a 30-minute speech and oral motion evaluation, in which they imitate sounds, words and oral movements while a speech pathologist evaluates their lip, tongue and palate movements. They may also be asked to drink a small amount of water for examination of swallowing function. For the ultrasound examination, a 3/4-inch transducer (device for transmitting and receiving sound waves) is placed under the participant's chin. While the transducer is in place, the subject 1) repeats sounds and a series of syllables in several sequences, 2) swallows three times with and without a small amount of water, and 3) swallows 3 teaspoons of non-fat pudding. The ultrasound images are recorded on tape for later analysis.
Conditions Studied
Study Locations (1)
Maryland
- Warren G. Magnuson Clinical Center (CC) - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 570 participants |
| Start Date | 1979-08 |
| Est. Completion | 2004-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00001167
The ClinicalTrials.gov registry entry for NCT00001167 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 570 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,002-participant average among 8 other Polymyositis trials with a reported enrollment target (43% lower). The listed sponsor is National Institutes of Health Clinical Center (CC), which has 338 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Polymyositis appearing as the primary indexed condition, and to 0 interventions.
NCT00001167 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT00001167 about?
NCT00001167 is a clinical study titled "Ultrasound Evaluation of Tongue Movements in Speech and Swallowing". This study will assess the use of ultrasound-a test that uses sound waves to produce images-as a diagnostic tool for evaluating speech and swallowing. The following categories of individuals may be eligible for this study: 1) healthy volunteers between 20 and 85 years old with normal speech and hea...
What is the current status of trial NCT00001167?
This trial is currently completed. The enrollment target is 570 participants. The study started on 1979-08. Estimated completion is 2004-11.
What conditions does trial NCT00001167 study?
This clinical trial studies the following conditions: Polymyositis, Speech Disorder, Pharyngeal Neoplasm, Otorhinolaryngologic Disease, Otorhinolaryngologic Neoplasm.
Who is sponsoring clinical trial NCT00001167?
This trial is sponsored by National Institutes of Health Clinical Center (CC), which has 338 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00001167 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Polymyositis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study to Understand How the Study Medicine Dazukibart Works in People With Idiopathic Inflammatory Myopathies
RECRUITING · Phase 3
-
Adult and Juvenile Myositis
RECRUITING
-
Rheumatology Patient Registry and Biorepository
RECRUITING
-
MIHRA - Patient-Rooted Insights for Shaping Myositis Science (PRISMS)
RECRUITING
-
Environmental Risk Factors for the Anti-synthetase Syndrome
RECRUITING
-
A Study to Investigate the Efficacy and Safety of Efgartigimod PH20 SC in Adult Participants With Active Idiopathic Inflammatory Myopathy.
ACTIVE NOT RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.